Search Results | Diabetes Care | American Diabetes Association

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy

Henry N. Ginsberg, Neil J. Hounslow, Yusuke Senko, Hideki Suganami, Pawel Bogdanski, Richard Ceska, Akos Kalina, Roman A. Libis, Tatiana V. Supryadkina, G. Kees Hovingh

Diabetes Care 2022;45(4):898–908

DOI: https://doi.org/10.2337/dc21-1288

Published: 25 March 2022

View article

Journal Articles

The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes

Ronald B. Goldberg, Neil J. Stone, Scott M. Grundy

Diabetes Care 2020;43(8):1673–1678

DOI: https://doi.org/10.2337/dci19-0036

Published: 10 July 2020

View article

Journal Articles

Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007–2014

Wenjun Fan, Sephy Philip, Craig Granowitz, Peter P. Toth, Nathan D. Wong

Diabetes Care 2019;42(12):2307–2314

DOI: https://doi.org/10.2337/dc19-0501

Published: 01 October 2019

View article

Journal Articles

Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes

Alexandre Jehl, Christine Cugnet-Anceau, Corinne Vigouroux, Anne L. Legeay, Stéphane Dalle, Olivier Harou, Lucien Marchand, Olivier Lascols, Cyrielle Caussy, Charles Thivolet, Martine Laville, Emmanuel Disse

Diabetes Care 2019;42(10):2008–2010

DOI: https://doi.org/10.2337/dc18-2535

Published: 21 August 2019

View article

Includes: Supplementary data

Journal Articles

Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy

John M. Dennis, Beverley M. Shields, Anita V. Hill, Bridget A. Knight, Timothy J. McDonald, Lauren R. Rodgers, Michael N. Weedon, William E. Henley, Naveed Sattar, Rury R. Holman, Ewan R. Pearson, Andrew T. Hattersley, Angus G. Jones

Diabetes Care 2018;41(4):705–712

DOI: https://doi.org/10.2337/dc17-1827

Published: 31 January 2018

View article

Includes: Supplementary data

Journal Articles

Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial

Eiichi Araki, Shizuya Yamashita, Hidenori Arai, Koutaro Yokote, Jo Satoh, Toyoshi Inoguchi, Jiro Nakamura, Hiroshi Maegawa, Narihito Yoshioka, Yukio Tanizawa, Hirotaka Watada, Hideki Suganami, Shun Ishibashi

Diabetes Care 2018;41(3):538–546

DOI: https://doi.org/10.2337/dc17-1589

Published: 03 January 2018

View article

Includes: Supplementary data

Journal Articles

Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes

Andres Digenio, Richard L. Dunbar, Veronica J. Alexander, Marcus Hompesch, Linda Morrow, Richard G. Lee, Mark J. Graham, Steven G. Hughes, Rosie Yu, Walter Singleton, Brenda F. Baker, Sanjay Bhanot, Rosanne M. Crooke

Diabetes Care 2016;39(8):1408–1415

DOI: https://doi.org/10.2337/dc16-0126

Published: 06 June 2016

View article

Includes: Supplementary data

Journal Articles

Metabolic Syndrome, Prediabetes, and Brain Abnormalities on MRI in Patients With Manifest Arterial Disease: The SMART-MR Study

Audrey M. Tiehuis, Yolanda van der Graaf, Willem P.T.M. Mali, Koen Vincken, Majon Muller, Mirjam I. Geerlings

Diabetes Care 2014;37(9):2515–2521

DOI: https://doi.org/10.2337/dc14-0154

Published: 07 August 2014

View article

Journal Articles

Cardiometabolic Risk Is Associated With Atherosclerotic Burden and Prognosis: Results From the Partners Coronary Computed Tomography Angiography Registry

Edward Hulten, Marcio Sommer Bittencourt, Daniel O'Leary, Ravi Shah, Brian Ghoshhajra, Mitalee P. Christman, Philip Montana, Michael Steigner, Quynh A. Truong, Khurram Nasir, Frank Rybicki, Jon Hainer, Thomas J. Brady, Marcelo F. Di Carli, Udo Hoffmann, Suhny Abbara, Ron Blankstein

Diabetes Care 2014;37(2):555–564

DOI: https://doi.org/10.2337/dc13-1431

Published: 11 January 2014

View article

Includes: Supplementary data

Journal Articles

Diabetes Prevention: How Important Is Geographic Divergence Regarding the Role of Fish Intake?

Judith Wylie-Rosett, EdD, RD, Karin B. Aebersold, MPH, Beth A. Conlon, MS, RD

Diabetes Care 2012;35(4):666–668

DOI: https://doi.org/10.2337/dc11-2485

Published: 13 March 2012

View article

Journal Articles

Triglycerides and Amputation Risk in Patients With Diabetes: Ten-year follow-up in the DISTANCE study

Brian C. Callaghan, MD, Eva Feldman, MD, Jennifer Liu, MPH, Kevin Kerber, MD, Rodica Pop-Busui, MD, Howard Moffet, MPH, Andrew J. Karter, PHD

Diabetes Care 2011;34(3):635–640

DOI: https://doi.org/10.2337/dc10-0878

Published: 17 February 2011

View article

Journal Articles

TRIB3 Functional Q84R Polymorphism Is a Risk Factor for Metabolic Syndrome and Carotid Atherosclerosis

Hui-ping Gong, MD, Zhi-hao Wang, MD, Hao Jiang, MD, Ning-ning Fang, MD, Ji-sheng Li, PHD, Yuan-yuan Shang, MD, Yun Zhang, MD, Ming Zhong, MD, Wei Zhang, MD

Diabetes Care 2009;32(7):1311–1313

DOI: https://doi.org/10.2337/dc09-0061

Published: 23 April 2009

View article

Includes: Supplementary data

Journal Articles

Targets for Intervention in Dyslipidemia in Diabetes

Gerald H. Tomkin, MD

Diabetes Care 2008;31(Supplement_2):S241–S248

DOI: https://doi.org/10.2337/dc08-s260

Published: 01 February 2008

View article

Journal Articles

Glucose Indices, Health Behaviors, and Incidence of Diabetes in Australia: The Australian Diabetes, Obesity and Lifestyle Study

Dianna J. Magliano, PHD, Elizabeth L.M. Barr, MPH, Paul Z. Zimmet, PHD, Adrian J. Cameron, MPH, David W. Dunstan, PHD, Stephen Colagiuri, FRACP, Damien Jolley, MSC, Neville Owen, PHD, Patrick Phillips, FRACP, Robyn J. Tapp, PHD, Tim A. Welborn, PHD, Jonathan E. Shaw, FRACP

Diabetes Care 2008;31(2):267–272

DOI: https://doi.org/10.2337/dc07-0912

Published: 01 February 2008

View article

Journal Articles

Errata

Diabetes Care 2008;31(1):187

DOI: https://doi.org/10.2337/dc08-er01

Published: 01 January 2008

View article

Journal Articles

Fenofibrate Therapy Ameliorates Fasting and Postprandial Lipoproteinemia, Oxidative Stress, and the Inflammatory Response in Subjects With Hypertriglyceridemia and the Metabolic Syndrome

Robert S. Rosenson, MD, David A. Wolff, MS, Anna L. Huskin, RN, BSN, Irene B. Helenowski, MS, Alfred W. Rademaker, PHD

Diabetes Care 2007;30(8):1945–1951

DOI: https://doi.org/10.2337/dc07-0015

Published: 01 August 2007

View article

Includes: Supplementary data

Journal Articles

Relationship Between Metabolic Risk Factor Clustering and Cardiovascular Mortality Stratified by High Blood Glucose and Obesity: NIPPON DATA90, 1990–2000

Aya Kadota, MD, Atsushi Hozawa, MD, Tomonori Okamura, MD, Takashi Kadowak, MD, Koshi Nakmaura, MD, Yoshitaka Murakami, PHD, Takehito Hayakawa, PHD, Yoshikuni Kita, PHD, Akira Okayama, MD, Yasuyuki Nakamura, MD, Atsunori Kashiwagi, MD, Hirotsugu Ueshima, MD, for the NIPPON DATA Research Group

Diabetes Care 2007;30(6):1533–1538

DOI: https://doi.org/10.2337/dc06-2074

Published: 01 June 2007

View article

Includes: Supplementary data

Journal Articles

A Risk Score for Predicting Incident Diabetes in the Thai Population

Wichai Aekplakorn, MD, PHD, Pongamorn Bunnag, MD, Mark Woodward, PHD, Piyamitr Sritara, MD, Sayan Cheepudomwit, MD, Sukit Yamwong, MD, Tada Yipintsoi, MD, Rajata Rajatanavin, MD

Diabetes Care 2006;29(8):1872–1877

DOI: https://doi.org/10.2337/dc05-2141

Published: 01 August 2006

View article

Journal Articles

The Prevalence of the Metabolic Syndrome Did Not Increase in Mexico City Between 1990–1992 and 1997–1999 Despite More Central Obesity

Carlos Lorenzo, MD, Ken Williams, MS, Clicerio Gonzalez-Villalpando, MD, Steven M. Haffner, MD

Diabetes Care 2005;28(10):2480–2485

DOI: https://doi.org/10.2337/diacare.28.10.2480

Published: 01 October 2005

View article

Journal Articles

Effect of Raloxifene on Serum Triglycerides in Women With a History of Hypertriglyceridemia While on Oral Estrogen Therapy

Molly C. Carr, MD, Robert H. Knopp, MD, John D. Brunzell, MD, Barbara S. Wheeler, RN, Xiaodong Zhu, MD, Mark Lakshmanan, MD, Amy S. Rosen, MS, Pamela W. Anderson, MD

Diabetes Care 2005;28(7):1555–1561

DOI: https://doi.org/10.2337/diacare.28.7.1555

Published: 01 July 2005

View article

NARROW

Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy

The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes

Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007–2014

Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes

Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy

Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial

Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes

Metabolic Syndrome, Prediabetes, and Brain Abnormalities on MRI in Patients With Manifest Arterial Disease: The SMART-MR Study

Cardiometabolic Risk Is Associated With Atherosclerotic Burden and Prognosis: Results From the Partners Coronary Computed Tomography Angiography Registry

Diabetes Prevention: How Important Is Geographic Divergence Regarding the Role of Fish Intake?

Triglycerides and Amputation Risk in Patients With Diabetes: Ten-year follow-up in the DISTANCE study

TRIB3 Functional Q84R Polymorphism Is a Risk Factor for Metabolic Syndrome and Carotid Atherosclerosis

Targets for Intervention in Dyslipidemia in Diabetes

Glucose Indices, Health Behaviors, and Incidence of Diabetes in Australia: The Australian Diabetes, Obesity and Lifestyle Study

Errata

Fenofibrate Therapy Ameliorates Fasting and Postprandial Lipoproteinemia, Oxidative Stress, and the Inflammatory Response in Subjects With Hypertriglyceridemia and the Metabolic Syndrome

Relationship Between Metabolic Risk Factor Clustering and Cardiovascular Mortality Stratified by High Blood Glucose and Obesity: NIPPON DATA90, 1990–2000

A Risk Score for Predicting Incident Diabetes in the Thai Population

The Prevalence of the Metabolic Syndrome Did Not Increase in Mexico City Between 1990–1992 and 1997–1999 Despite More Central Obesity

Effect of Raloxifene on Serum Triglycerides in Women With a History of Hypertriglyceridemia While on Oral Estrogen Therapy

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only